Bowling Portfolio Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Bowling Portfolio Management's BIIB Position: Q3 2022 in Review
Bowling Portfolio Management reduced its Biogen (BIIB) stake by 28% in Q3 2022, selling an estimated $75K and leaving 928 shares worth $248K. The position accounts for 0.07% of the portfolio, ranked #171.
Bowling Portfolio Management first reported a position in BIIB in Q1 2017 and has held it in 21 quarters since. The position peaked at $5.71M in Q4 2019. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- Bowling Portfolio Management held 928 shares of Biogen worth $248K as of Q3 2022.
- Bowling Portfolio Management sold 353 Biogen shares in Q3 2022, an estimated $75K.
- Biogen made up 0.07% of Bowling Portfolio Management's portfolio in Q3 2022, its #171 holding.
- Bowling Portfolio Management first reported a position in Biogen in Q1 2017 and has held it in 21 quarters since.
- Bowling Portfolio Management's Biogen position peaked at $5.71M in Q4 2019.
- 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.